If this message is not displayed correctly, click here.


No 101, April 2017


The slides of the first 2017 CME Course are now available on the European Nephrology Portal (ENP)!

The “Pitfalls of pharmacotherapy in chronic kidney disease” CME Course organised by the Czech Society of Nephrology and ERA-EDTA, was held in Prague (Czech Republic) on January 20-21, 2017.
The slides of this educational event are now available on ENP. Click here to access them (access is for ERA-EDTA members only)!


Help us create the 2018 ERA-EDTA Educational Programme

All ERA-EDTA full members are potential CME organisers. If you are an ERA-EDTA member and you wish to actively contribute to the creation of the 2018 ERA-EDTA Educational Programme, do not miss the opportunity to organise an educational course in your country and apply for ERA-EDTA support.*
For new courses to be organised in the 1st semester of 2018 applications must be submitted by June 15, 2017; for new courses organised in the 2nd semester of 2018, the deadline is December 15, 2017. CME proposal can only be submitted electronically at https://www.era-edta.org/cme/index.php
For further information, do not hesitate to contact us by sending an e-mail to: education@era-edta.org.

*The educational programme for 2018 does not include CMEs held during the 55th ERA-EDTA Congress (Copenhagen, Denmark – May 24-27, 2018).

ndt and ckj articles

Just published online! Read the latest NDT and CKJ articles

Milestones in CKD from 2007 to 2016
This review gives an overview of milestones in CKD in the previous ten years: the introduction of the new equations for estimating glomerular filtration rate (GFR), the addition of albuminuria categories to the staging of CKD or the genome-wide association studies that generated insights into genetic polymorphisms – these are only three examples of innovations that paved nephrology´s way and established CKD as a condition that is common, harmful and treatable. Find out more about innovative developments and follow the authors´ discussion on what lessons can be learnt from epidemiological investigations of the staging, etiology, prevalence and prognosis of CKD between 2007 and 2016.

Better cardioprotective treatment in renal protection clinics?
87–90% of CKD patients suffer from hypertension, 43% from dyslipidaemia and 37–38% from diabetes. Therefore, the actual guidelines emphasize the importance of recognizing and addressing cardiovascular risk factors by using appropriate cardioprotective drug therapy. This observational study examined the impact of referral and follow-up in a renal protection clinic for patients with CKD by analyzing the prescription patterns of and adherence to antihypertensive and lipid-lowering agents over a 1-year follow-up period. The study suggests that referral to renal protection clinics may have a positive impact on the prescription of cardioprotective drug therapy in CKD patients - but unfortunately, it does not seem to modify adherence to cardioprotective drugs.


DESCARTES and ERBP publication was top-read paper in the "Transplant Library" 2016!

DESCARTES and ERBP publication was top-read paper in the "Transplant Library" 2016!

In May 2016, the paper "Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBP" was published in Nephrology, Dialysis and Transplantation (NDT). The publication was the most popular article in the "Transplant Library" in 2016 and was read more than 700 times.

The review showed that pre-emptive transplantation in patients with a living donor can improve patient and graft survival and reduces the risk of acute rejection.

Web Site

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy


The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003. If at any time you wish to change personal information that is incorrect or wish to have your personal data deleted, please REPLY this email and specify ‘REMOVE ME FROM YOUR DATABASE’. ERA-EDTA will meet such requests at the earliest possible opportunity by deleting or amending your personal information.